Kashewar tsarin tsarin kwayoyin halitta na dopamine don amsawa ga abincin mai girma (2013)

. Rubutun marubuci; akwai a cikin PMC 2014 Yuni 1.

An buga shi a cikin tsari na karshe kamar yadda:

PMCID: PMC3700634

NIHMSID: NIHMS435903

Abstract

Manufa

Don gwada ko abincin mai mai yawa (HFD) yana rage sautin dopaminergic a cikin ladan kwalliyar kwakwalwa da kimanta ko waɗannan canje-canje sun juye bayan cire HFD.

Tsara da Hanyoyi

An ciyar da man mata da aan mace 60% HFD na makonni 12. An sake nazarin ƙarin rukunin ƙungiyar 4 makonni bayan cire HFD. Wadannan kungiyoyi an kwatanta su da sarrafawar sarrafa abinci, abubuwan tsufa. An auna fifiko na Sucrose da saccharin tare da mRNA na bayyanar kwayoyin halittar dopamine ta RT-qPCR. Dopamine da DOPAC an auna su ta amfani da sinadaran ruwa na kayan maye. An auna methylation na DNA na mai inganta DAT ta hanyar methylated DNA immmunoprecipitation da RT-qPCR.

results

Bayan na yau da kullun HFD, an rage fifikon nasarar maye, sannan kuma bisa al'ada bayan an cire HFD. Rage bayyana kwayoyin halittar dopamine, rage yawan abubuwan dopamine da sauye-sauye a cikin tsarin DAT na inganta methylation. Mahimmanci, amsa ga HFD da kuma dagewar canje-canje sun dogara ne akan jima'i da yankin kwakwalwa.

karshe

Waɗannan bayanan suna gano saukad da ƙarancin dopamine bayan rayuwar farko-ta ƙwanƙwasa HFD tare da yanayin mahalli na sakewa da dagewa wanda ya bambanta ta hanyar jima'i da yankin kwakwalwa. Canje-canje na CNS wanda bai juya baya ba bayan cirewar HFD na iya ba da gudummawa ga wahalar riƙe nauyin-asara bayan sahun abinci.

keywords: Dopamine, Abincin mai mai-yawa, DAT, bambance-bambancen jima'i, kiba, cirewa, DNA methylation

Gabatarwa

Ana ɗaukar yawan cin abinci mai daɗi da ake samu a ko'ina, mai yawan kalori a matsayin babban abin da ke haifar da yawan kiba a Amurka ( ). Saboda ana cin abinci mai daɗi sau da yawa bayan an cika buƙatun kuzari, kaddarorin abinci masu daɗi na iya wuce siginar gamsuwa ta homeostatic. Yawancin masu jijiyoyi suna taka rawa wajen halayyar ciyarwa (misali opioids, dopamine, GABA, serotonin) da kuma haɗakar siginar abinci mai gina jiki (misali, leptin, insulin, ghrelin). Siginar Dopamine babban mai shiga tsakani ne a cikin ladan abinci da kuma halayen neman lada, kamar yadda dopamine a yankin mesolimbic/mesocortical yana da alaƙa da kaddarorin lada na abinci, jima'i, da magungunan jaraba ( ). A zahiri, abinci mai daɗi yana haifar da fashewar dopamine a cikin tsarin lada na tsakiya ( , ). Tare da yawan cin abinci mai lada, ƙaruwar sakin dopamine akan lokaci na iya haifar da daidaitawa waɗanda ke da alaƙa da aikin lada.

Shaidu da dama sun goyi bayan hasashen cewa aikin dopamine ya canza a cikin kiba. Nazarin hoton ɗan adam ya nuna cewa an kunna shi a yankunan lada na marasa lafiya masu kiba yayin da suke shan maganin da ke da daɗi sosai (milkshake) ( ). Amsar lada mai laushi tana da alaƙa da ƙarancin wadatar mai karɓar dopamine na kwakwalwa D2. A zahiri, maye gurbi a cikin mai karɓar dopamine D2 na ɗan adam an danganta shi da kiba da jaraba ( ). Abubuwan da ke cikin dopamine a cikin synapse galibi ana sarrafa su ta hanyar ɗaukar mai jigilar dopamine (DAT). Matakan mai jigilar dopamine suna da alaƙa da ma'aunin taro na jiki kuma bambance-bambancen kwayoyin halitta na DAT suma suna da alaƙa da kiba ( , ). Samfuran dabbobi masu kiba sun nuna raguwa a cikin dopamine na basal extracellular da rage dopamine neurotransmission a cikin ƙwayoyin nucleus da yankin ventral tegmental ( , , ). Ragewa a cikin kwayoyin halittar da ke da alaƙa da dopamine bayan cin abinci mai yawan kitse (HF) yana nuna raguwar sigina a yankunan lada ( , , , ). Wannan raguwar ayyukan dopamine bayan cin abinci mai yawan kitse na yau da kullun na iya rage yawan lada ga lada na halitta da kuma sauƙaƙe ci gaba da shan ƙwayoyi da ƙarin ƙarin nauyi.

Rayuwar farko lokaci ne mai matuƙar muhimmanci a cikin ci gaban kwakwalwa, kuma yanayin abinci mai gina jiki na farko zai iya yin tasiri ga hanyoyin kwakwalwa da ke sarrafa yawan cin abinci da kuma yadda ake sarrafa kuzari. Bayyanar beraye da wuri ga abinci mai yawan kitse na ɗan lokaci kaɗan na tsawon mako guda ya canza yawan kalori na manya da kuma bayyanar ƙwayoyin siginar da ke da alaƙa da dopamine ( ). Bugu da ƙari, farkon haihuwa bayan haihuwa fiye da abinci mai gina jiki a cikin beraye, wanda ƙaramin adadin 'ya'yan itace ke haifarwa a lokacin shayarwa, yana sa 'ya'yan su ga kiba ta hanyar canza ci gaban hypothalamic ( ). Duk da yake a bayyane yake cewa abinci mai gina jiki na farkon rayuwa na iya shafar ci gaban kwakwalwa da haɗarin kiba, ba a san komai game da dorewar waɗannan canje-canje a tsawon rayuwa ba. Bugu da ƙari, an yi nazarin da aka yi a baya a cikin dabbobin maza amma ba a yi nazari sosai kan mata a wannan mahallin ba. Don waɗannan manufofin, an yi nazarin beraye maza da mata don canje-canje a cikin bayyanar kwayoyin halitta da metabolism na dopamine bayan an yi musu kiba a farkon rayuwa ta hanyar cin abinci na HF na tsawon lokaci daga haihuwa har zuwa makonni 8 na haihuwa. An kuma tantance tsarin dopamine makonni 4 bayan cire abincin HF, don bincika ko canje-canjen sun ci gaba ko sun koma baya.

Hanyoyi da Hanyoyi

Dabbobi da samfurin gwaji

An batar da mata na C57BL / 6J tare da maza DBA / 2J (The Jackson Laboratory, Bar Harbor, ME). An ciyar da dukkanin dam din daidaitaccen tsarin sarrafa abinci (#5755; furotin 18.5%, 12% mai, 69.5% carbohydrate) har zuwa lokacin da aka sanya rabin dam / litter a kan abinci mai mai (Abincin Gwaji, Richmond, IN #58G9; 18%) furotin, kitse na 60%, da sinadarin carbohydrate na 20.5%). An yayan 'ya' yan 'Ya'yansu a makonni na 3 kuma sun ci gaba da kasancewa a kan ko dai abinci mai sarrafawa ko abinci mai mai yawa har zuwa makonni 12. An yi rikodin nauyin jikin mutum mako-mako, kuma anyi amfani da maza (n = 5 – 10) da mace (n = 5 – 10) mice. Kwamitin Kula da Dabbobin dabbobi da Cibiyoyin IACUC na Jami'ar Pennsylvania sun amince da duk matakan.

Zabin Sucrose da Saccharin

A gwaje-gwaje daban-daban, an ajiye beraye daban-daban (n=8–10/rukuni) a cikin keji na yau da kullun na tsawon kwanaki 3 tare da kwalba ɗaya na 200 ml na maganin gwaji (4% sucrose ko 1% saccharin maganin (w/v)) da kuma wata kwalba da 200 ml na ruwan famfo. An sami chow na gida ad libitum . An auna sucrose (ml), ruwa (ml), da abincin da ake ci (g), kuma an mayar da wurin da aka sanya kwalaben a kowace rana. An ƙididdige fifiko ta amfani da matsakaicin ma'aunin kwanaki 2 da suka gabata kamar haka: fifiko % = [(cin sucrose/sucrose + shan ruwa) × 100].

Kwayoyin halittar DNA da rabuwa da RNA daga kwakwalwa

An kashe dabbobi (n=5/rukuni) ta hanyar amfani da yawan iskar carbon dioxide, sannan aka sake samun matsala a mahaifa; wata hanya da Kwamitin Kula da Euthanasia na Ƙungiyar Likitocin Dabbobin Amurka ya ba da shawarar. Daga nan aka cire kwakwalwa cikin sauri aka sanya ta a cikin RNAlater (Ambion, Austin, TX) na tsawon awanni 4-6 kafin a raba ta. An riga an tsara rarrabawar kwakwalwa don ware prefrontal cortex, nucleus accumbens da yankin ventral tegmental kamar yadda aka bayyana a baya ( , , ). An ware DNA na genomic da jimillar RNA a lokaci guda ta amfani da AllPrep DNA/RNA Mini Kit (Qiagen).

Binciken bayanan Gene ta hanyar PCR-Real-Time

Ga kowane samfurin mutum ɗaya, an yi amfani da jimlar RNA 500ng a cikin rubutun baya ta amfani da Babban Kayan Kwafi na Juyawa (ABI, Foster City, CA). An ƙayyade bayyanar kwayoyin halittar da aka yi niyya ta hanyar amfani da ƙididdigar RT-PCR ta amfani da Taqman Probes na musamman na kwayoyin halitta tare da bayyanar kwayar halittar Taqman Master Mix (ABI) akan ABI7900HT Real-Time PCR Cycler. An jera binciken kwayoyin halitta a cikin kayan ƙarin . An ƙayyade adadin kowane rubutun ta amfani da ƙimar delta CT kamar yadda aka bayyana a baya a cikin ( ). An ƙididdige canje-canje a cikin bayyanar kwayar halitta akan ma'aunin GAPDH wanda ba a canza ba.

Ex vivo Dopamine da Dopamine Metabolites

An yi amfani da babban aikin ruwa mai aiki (HPLC) don auna abun da ke cikin dopamine da metabolites a cikin sassan lada na mesolimbic na kwakwalwa (n=8–12), kamar yadda aka bayyana a baya ( , ). An tattara kwakwalwa daga dabbobi kuma aka raba su zuwa sassan dama da hagu. An rarraba NAc da PFC kuma an daskare su da sauri ta hanyar busasshen kankara kuma an adana su a −80°C. An shirya kyallen don bincike ta hanyar daidaitawa a cikin 0.1 N perchloric acid, an sanya shi a 15,000 rpm na minti 15 a 2–8°C, sannan aka tace saman. An yi nazarin samfuran ta hanyar Bioanalytical Systems HPLC (West Lafayette, IN, Amurka) ta amfani da na'urar gano lantarki ta LC-4C. An yi wa samfuran (12 ul) allura a kan ginshiƙin microbore na juyi a kan ƙimar kwararar 0.6 ml/min kuma an saita electrodetection a +0.6 V. An cimma rabuwar dopamine da metabolites na dopamine ta hanyar wani mataki na motsi wanda ya ƙunshi sodium acetate 90-mM, citric acid 35-mM, ethylenediamine tetraacetic acid 0.34-mM, sodium octyl sulfate 1.2-mM, da 15% methanol v/v a pH na 4.2. An auna tsayin samfuran kuma an kwatanta su da ƙa'idodi don dopamine da metabolite 3,4-dihydroxyphenylacetic acid (DOPAC).

Methylated DNA Immunoprecipitation (MeDIP) Assay

An tsara MeDIP assay ta amfani da kit ɗin MagMeDIP (Diagenode, Denville, NJ). Methylated DNA yana immunoprecipised ta amfani da 0.15ul na beraye masu rufi waɗanda aka ɗauka tare da maganin anti-5methylcytidine antibody (Diagenode) ko ƙwayar rigakafi ta rigakafi. Haɓaka ƙaddamarwa a cikin yanki na MeDIP an ƙaddara ta ƙaddara RT-PCR ta amfani da ChIP-qPCR Assay Master Mix (SuperArray) akan ABI7900HT Cycler Real-Time. Ga duk kwayoyin da aka bincika, an samo firayimta ne daga SuperArray (ChIP-qPCR Assays (−01) kb tile, SuperArray) don haɓaka yankuna na kwayoyin halitta da ke gudana a cikin rukunin gidajen yanar gizon CpG da ke kusan 300-500 bp sama na wuraren fara rikodin. Sakamakon MeDIP an bayyana shi azaman girman haɓakar ƙarancin DNA na kowane rukunin yanar gizon. Don ƙididdige canjin girma mazaunin canji (haɓakawa)%, darajar MeDIP DNA juzu'in CT ƙimar dabi'un Input DNA ƙimar CT.

statistics

An gudanar da nazarin maganganun Gene ta amfani da T-test student wanda ke kwatanta tsofaffin matakan da suka dace da kungiyoyin HF da HF +. An daidaita matakin alpha don yankuna kwakwalwa da yawa da aka bincika. Mahimmancin tsararraki da aka yi amfani da shi a yankin kwakwalwa ɗaya shine p = .05; don yankuna biyu, p = 0.025, don yankuna kwakwalwa na 3 p = .016. Abun zaɓi na Sucrose, fifiko na saccharin, HPLC da MEDIP, nauyin jikin mutum da corticosterone assay sunyi nazari ta amfani da hanya daya ta ANOVA don kwatanta sarrafawa, HF, da HF + kungiyoyin dawo da su. Anyi amfani da gwaji da yawa na Post-hoc Bonferonni don kwatanta bambance-bambancen mai hikima tsakanin kungiyoyi. An saita mahimmancin waɗannan gwaje-gwaje a matakin alpha na p = .05.

results

Beraye suna da damar ci gaba da cin abinci mai sarrafawa (ikon sarrafawa) ko kuma kashi 60% na abincin mai mai yawa (HFD) har zuwa makonni 12. A makonni 12 na haihuwa, rabin dabbobin da aka ciyar da HF an sanya su a kan abincin gida na tsawon makonni 4 (HF + murmurewa). A cikin maza da mata, dabbobin HFD (da'ira) sun fi nauyi fiye da na sarrafawa tun daga makonni 9 na haihuwa (p <.05) kuma sun kasance sun fi nauyi fiye da na sarrafawa a duk lokacin murmurewa ( Karin Hoto na 1 ).

An gudanar da gwaje-gwajen fifikon sucrose da saccharin don tantance martanin dabbobi ga abubuwan da ke haifar da sakamako na halitta da na rashin abinci mai gina jiki. An canza fifikon sucrose amma ba saccharin ba bayan fallasa abinci ga HF kuma ya koma matakan da suka dace bayan murmurewa daga HFD a cikin maza da mata. Hanya ɗaya ta ANOVA ta nuna cewa fifikon sucrose ya ragu sosai a cikin maza ( Hoto na 1A ) kuma ya koma ga raguwar mata ( Hoto na 1B ) bayan fallasa HFD (F(2,16)=4.82, p<.05; F(2,16)=5.41, p<.06, bi da bi). Bayan cire HFD, wannan ɗabi'a ta daidaita kuma fifikon sucrose bai sake bambanta da sarrafawa ba. fifikon Saccharin bai canza ba a cikin maza ( Hoto na 1C ) ko mata ( Hoto na 1D ) sakamakon fallasa HFD.

Figure 1 

Abinda ake so a cikin Sucrose amma ba saccharin fifikon an canza shi bayan bayyanar abincin mai mai yawa (HFD) kuma ya koma matakan sarrafawa bayan dawowar HFD a cikin maza da mata

Saboda dopamine muhimmin abu ne na daidaita halayen lada, an bincika bayyanar kwayoyin halitta da suka shafi dopamine a cikin da'irar lada ta wani rukunin maza da mata daban bayan makonni 12 akan HFD, da kuma a cikin wani rukuni, bayan murmurewa daga makonni 4 daga HFD. Tebur 1 ya taƙaita tsarin bayyanar kwayoyin halitta da nazarin kididdiga a cikin VTA, PFC da NAc. A cikin VTA, an auna kwayoyin halitta guda uku masu mahimmanci wajen daidaita matakan dopamine a tashoshin synaptic: catecholamine methyl transferase (COMT) da ke da hannu wajen hana kunna masu karɓar ƙwayoyin cuta na catecholamine; mai jigilar dopamine (DAT), famfon membrane wanda ke share dopamine daga synapse, da tyrosine hydroxylase (TH), enzyme mai iyakance ƙimar don haɗa dopamine. An ƙayyade ƙimar canjin ninka don kowane rukuni ta amfani da sarrafawa masu dacewa da shekaru (misali duka lokutan sarrafawa an saita su zuwa 1, kuma don haske kawai ana nuna ikon HFD akan jadawalin). Gwajin t-test na ɗalibi (n=5/rukuni) ya bayyana a cikin VTA na maza cewa COMT, DAT, da TH mRNA sun ragu sosai ta hanyar fallasa HFD ( Hoto na 2A ) kuma sun koma ko sun wuce matakan sarrafawa bayan lokacin murmurewa daga abinci (HF + murmurewa).

Figure 2 

Abincin mai kitse mai tsoka (HFD) da warkewa bayan HFD ya canza maganin magana game da cutar ɗimbin ƙwayoyin cuta a cikin maza da mata
Table 1 

Takaita rayuwar Gene da isticsididdiga a Maza

A cikin PFC da NAC, an binciki kwayoyin halitta masu mahimmanci ga siginar dopamine da juyawar dopamine (n=5/rukuni): COMT; furotin phosphatase 1 regulatory subunit 1B (DARPP-32), furotin siginar downstream wanda aka tsara ta hanyar ƙarfafa masu karɓa; dopamine receptor D1 (DRD1), wani mai karɓar G-protein mai haɗin gwiwa na postsynaptic wanda ke motsa adenylyl cyclase; da kuma dopamine receptor D2 (DRD2), wani mai karɓar G-protein mai haɗin gwiwa na postsynaptic wanda ke hana adenylyl cyclase. A cikin namiji PFC ( Hoto na 2B ), an ƙara DARPP-32, yayin da DRD1, da DRD2 suka ragu bayan fallasa HFD, kuma waɗannan canje-canjen sun ci gaba bayan cire HFD (kodayake ƙaruwar DARPP-32 mRNA ba ta da tabbas a kididdiga). A cikin namiji NAC ( Hoto na 2C ), COMT, DRD1, da DRD2 sun ragu ta hanyar fallasa HFD, kuma sun kasance ƙasa da matakan sarrafawa bayan cire HFD. Matakan DARPP-32 sun ƙaru ta hanyar HFD, amma sun ragu sosai daga sarrafawa bayan makonni 4 da suka rage daga HFD.

An duba sassan kwakwalwa da kwayoyin halitta iri ɗaya a cikin beraye mata (n=5/rukuni). Kamar yadda aka nuna a cikin Tebur 2 , an lura da bambance-bambance masu mahimmanci a cikin tsarin bayyanar kwayoyin halitta a cikin martani ga HFD, da kuma murmurewa daga abinci. Kamar maza, a cikin VTA, matakan mRNA na COMT, da TH sun ragu sosai bayan fallasa HFD ( Hoto na 2D ). Duk da haka, ba kamar maza ba, waɗannan canje-canje sun ci gaba bayan cire HFD. Bugu da ƙari, a cikin adawa kai tsaye ga tsarin da aka lura a cikin maza, fallasa HFD ya ƙara bayyanar DAT mRNA a cikin VTA a cikin mata, kuma bayan cire matakan HFD sun ma yi ƙasa da ikon sarrafawa na shekaru. A cikin PFC, DARPP-32 ne kawai ya shafa ta hanyar HFD na yau da kullun, tare da ƙaruwa mai yawa a cikin matakan mRNA bayan makonni 12 na HFD, da kuma komawa zuwa matakan sarrafawa bayan cire HFD. Dukansu COMT da D1R mRNA sun ragu sosai bayan makonni 4 daga HFD. A cikin NAC na mata, COMT, DRD1, da DRD2 duk sun ragu bayan fallasa HFD ( Hoto na 2F ). DRD1 da DRD2 sun murmure zuwa matakan sarrafawa bayan cire abinci, yayin da matakan COMT suka kasance raguwa sosai bayan murmurewa na makonni 4.

Table 2 

Takaita rayuwar Gene da Geneididdiga a cikin Mace

Ganin raguwar da aka samu a yawan bayyanar kwayoyin halitta na dopamine da ke daidaita kwayoyin halitta a cikin VTA, an ƙididdige ƙwayoyin halittar dopamine da dopamine a yankunan da ke karɓar hasashen daga VTA, PFC da NAC. Hoto na 3 ya nuna dopamine (DA) da dopamine metabolite (DOPAC) daga PFC da NAC a cikin maza ( Hoto na 3A, 3C ) da mata ( Hoto na 3B, 3D ). A cikin maza, fallasa ga HFD ya haifar da raguwar matakan dopamine a cikin PFC ( Hoto na 3A ) da NAC ( Hoto na 3C ) (F(2,13)=3.95; F(2,18)=3.536, p<.05), wanda ya warke bayan cire HFD kawai a cikin NAC. Juyawar dopamine (rabo na DOPAC:DA) ya ƙaru a cikin PFC na maza (F(2,12)=3.85, p<.05) da NAC (F(2,17)=4.69, p<.05). Sabanin haka, tasirin HFD akan DA da DOPAC a cikin mata ya bambanta da na maza a cikin inganci. A cikin PFC, HFD bai shafi matakan DA ko DOPAC ba. A cikin NAc, matakan DA sun ragu a cikin dabbobin da aka ciyar da HFD kuma sun kasance raguwa koda bayan cire HFD ( Hoto na 3D , F(2,23)=4.79, p<.05). Matakan DOPAC ba su canza ba a cikin NAc na mata, wanda ya haifar da ƙaruwa a cikin juyawar DA (rabo na DOPAC:DA) (F(2,23)=7.00, p<.01).

Figure 3 

Ragewa cikin matakan Dopamine a cikin PFC da NAC bayan HFD daga haihuwa da cakuda murmurewa bayan cire HFD

Ganin cewa ana iya daidaita kwafin DAT ta hanyar bambancin methylation na DNA da kuma lura da bambancin jinsi a cikin bayyanar DAT a cikin VTA, an sake duba methylation na DNA a yankin mai gabatarwa na DAT. A cikin Hoto na 4A, an sake gabatar da bayyanar kwayar halittar DAT ta 4C a cikin VTA don bayyanawa (wanda aka ɗauka daga Hoto na 2A da 2D ). An ƙara yawan methylation na mai haɓaka DAT sosai a cikin maza ( Hoto na 4B ) bayan HFD kuma an dawo da shi zuwa matakan sarrafawa a cikin mazan murmurewa na HFD + (F(2,11)=23.64, p<.01). A cikin mata, methylation na mai haɓaka DAT ya koma ga raguwa a cikin dabbobin HFD (D) kuma an ragu sosai a cikin mata masu murmurewa na HFD + (Hoto na 5D, F(2,12)=5.70, p<.05).

Figure 4 

Canje-canje a cikin yanayin methylation na DNA game da canje-canje masu tasowa na DAT daidai da bayyanawar asali a cikin VTA

Domin tantance ko cire HFD a lokacin murmurewa ya kasance abin damuwa, an ɗauki matakan corticosterone na plasma na asali (ug/dl) a cikin iko, an fallasa HFD (makonni 12), murmurewa HFD + makonni 1 da ƙungiyoyin murmurewa HFD + makonni 4 (n=5/rukuni, Ƙarin Hoto na 2 ). Hanya ɗaya ta ANOVA ta nuna babu wani bambanci mai mahimmanci tsakanin ƙungiyoyi a cikin dabbobin maza (F(3,16)=3.21, ns).

tattaunawa

Yawan amfani da mai kitse mai yawa (HFD) wanda ya fara a farkon rayuwa an yi amfani dashi don kafa kiba-rage yawaitar abinci a cikin mice. Mice ta nuna fifikon raguwar maye gurbinsa da shaidar rage dopaminergic tone a cikin ladan kwalliyar kwakwalwa. Bayan makonni 4 na kashe HFD, an zaɓi furucin mazaɓar fata a cikin maza da mata, duk da haka, wasu canje-canje na ƙayyadadden ɗaba'ar dopamine sun ci gaba. Wadannan gwaje-gwajen suna ba da sabon mahimman bayanai waɗanda ke bayyana tasirin HFD na kullum akan tsarin lada na kwakwalwa, yana nuna ikon murmurewa da mahimman bambance-bambancen jima'i tsakanin maza da mata.

A cikin dabbobin da aka ciyar da HFD, an lura da raguwar fifikon sucrose, wanda ya koma bayan lokacin murmurewa. Waɗannan binciken sun faɗaɗa rahotonmu na baya game da shan HFD wanda ke haifar da raguwar fifikon sucrose ( ) ta hanyar nuna cewa wannan na iya faruwa tare da ɗan gajeren lokacin fallasa HFD (makonni 12 idan aka kwatanta da makonni 22), kuma mahimmanci, cewa martanin yana murmurewa idan babu HFD. Beraye mata sun nuna irin tsarin amsawa iri ɗaya da maza. Waɗannan binciken sun yi daidai da wasu a cikin wallafe-wallafen da suka nuna ta hanyar haɗa ƙungiyar ciyarwa biyu cewa HFD na yau da kullun, ba kiba ba, yana rage martanin sucrose a cikin aikin aiki ( ). Hakazalika, a cikin binciken da ake yi yanzu, fifikon sucrose ya dawo bayan makonni 4 daga HFD, yayin da nauyin jiki ya kasance mai girma sosai, yana goyan bayan ƙarshe cewa raguwar fifikon sucrose ya samo asali ne ta hanyar fallasa HFD ba karuwar nauyin jiki da ke tare da shi ba. Abin sha'awa ne musamman cewa babu canji a fifikon saccharin. Wannan na iya nuna cewa HFD na yau da kullun yana shafar martanin lada mai daɗi na caloric da mara kalori. An nuna cewa tasirin bayan cin abinci yana tasiri ga fifiko ba tare da la'akari da dandano ba, kamar yadda aka nuna cewa shan sucrose yana haifar da sakin dopamine a cikin beraye masu karɓar ɗanɗano "masu zaki da makanta" ( ), ana buƙatar ƙimar abinci mai gina jiki don lada da ƙarfafawa ( ) kuma an ayyana hanyoyin fahimtar metabolism masu zaman kansu na ɗanɗano a cikin drosophila ( ). Saccharin ya fi sucrose zaƙi sosai, don haka an yi ƙoƙari don tabbatar da daidaito a cikin zaki (yawanci yawan sucrose sau 4-10 mafi girma ( )) duk da haka fifikon saccharin gabaɗaya ya yi ƙasa da na sucrose a cikin waɗannan dabbobi. Saboda haka, wani bayani na iya zama cewa HFD ya shafi fifikon sucrose daban-daban saboda ya fi lada fiye da saccharin (lada mai girma da ƙarancin ƙima), kodayake dabbobi har yanzu suna nuna fifiko mai ƙarfi ga saccharin (~75-80% fifiko ga saccharin idan aka kwatanta da ~85-90% fifiko ga sucrose).

Gabaɗaya, bayyanar kwayoyin halittar dopaminergic a cikin VTA, NAc da PFC ya ragu a cikin beraye maza bayan HFD na yau da kullun. Waɗannan binciken sun yi daidai da sauran nazarin da suka lura da raguwar kwayoyin halittar da ke da alaƙa da dopamine a cikin martani ga HFD ( , , ). An lura da raguwar bayyanar dopamine D2 da aikin mai karɓar dopamine a cikin nazarin hoton ɗan adam ( , ) da samfuran kiba na beraye ( , ). Rage siginar dopamine yana rage jin daɗin lada na halitta kuma saboda haka yana iya sauƙaƙe ci gaba da cin abinci mai daɗi da ƙarin nauyi ( , ). Bugu da ƙari, an san cewa rashin daidaituwar dopamine homeostasis wanda aka haifar ta hanyar raguwar bayyanar saman DAT yana haifar da ƙaruwar cin abinci mai mai mai yawa ( ). An ga wani keɓancewa ga wannan tsarin tare da DARPP-32, wani phosphoprotein mai tsari na dopamine da cyclic AMP, wanda ya ƙaru bayan HFD a cikin NAc da PFC. DARPP-32 yana taka muhimmiyar rawa wajen haɗa nau'ikan amsoshin biochemical da halayya iri-iri da dopamine ke sarrafawa. Wataƙila ƙaruwar DARPP-32 ya kasance diyya ga tsarin rage raguwar D1R na yau da kullun. A cikin wani tsari makamancin haka (makonni 12 na HFD a cikin beraye), an nuna cewa tsarin rage raguwar D1R ya daidaita ta hanyar ƙaruwar phosphorylation na DARPP-32 a cikin NAc ( ).

Bincike kaɗan ne suka binciki ƙarfin murmurewa daga waɗannan canje-canjen bayan cire HFD. Duk da haka, a cikin rahotanni guda biyu da suka gabata, canje-canjen bayyanar kwayoyin halitta da lahani na tsarin lada sun ci gaba bayan ɗan gajeren lokacin cirewa (14-18d) ( , ). Sabanin haka, nazarin da aka yi a cikin marasa lafiya masu kiba kafin da kuma bayan tiyatar gastrointestinal bypass ya nuna koma bayan canje-canjen dopaminergic bayan tsawon lokaci na asarar nauyi ( ). A cikin maza, yanayin murmurewa ya bambanta dangane da yankin kwakwalwa. A cikin VTA, raguwar da aka lura a cikin COMT, DAT, da TH duk an daidaita su tare da cire HFD. Sabanin haka, duk canje-canjen bayyanar kwayoyin halitta da aka lura a cikin NAc da PFC ba su daidaita ba. A cikin binciken da ake yi a yanzu, HFD na yau da kullun ya haifar da ƙaruwar nauyi mai yawa kuma bayan makonni 4 daga cin abinci, dabbobi har yanzu sun fi nauyi fiye da sarrafawa. Saboda haka, canje-canjen metabolism da hormonal da suka biyo baya waɗanda ke tare da kiba (misali, ƙaruwar leptin, haɓakar adipokines) wataƙila har yanzu suna nan a makonni 4 daga cin abinci. Saboda haka, canje-canjen bayyanar kwayoyin halitta waɗanda aka daidaita (misali, a cikin VTA) wataƙila HFD ne ke haifar da su, yayin da waɗanda aka kiyaye (a cikin NAc da PFC) na iya kasancewa sun fi haɗuwa da kiba. Kula da rage nauyi ta hanyar cin abinci yana da ƙarancin halaye (tare da kashi 67% ( ) zuwa 80% ( ) na marasa lafiya da suka sake samun nauyin da aka rasa). Wannan dorewar canje-canjen bayyanar kwayoyin halitta a yankunan lada na iya zama mahimmanci wajen bayyana wannan abin da ya faru akai-akai. Hakanan yana da mahimmanci a lura cewa canje-canjen halaye da bayyanar kwayoyin halitta da aka lura ba su da yuwuwar zama saboda damuwa da ke da alaƙa da canza abinci, kamar yadda babu manyan canje-canje a matakan corticosterone na basal plasma akan HFD ko bayan murmurewa na makonni 1 ko makonni 4.

An bayyana bambance-bambance na jima'i masu ban sha'awa, duka a cikin martani ga HFD na kullum, kamar yadda kuma don cire abinci. Mace sun yi kama da maza wajen nuna raguwar gaba ɗaya cikin kwayoyin halittar dopamine waɗanda ke iya hasashen raguwa a ayyukan DA, musamman a cikin VTA da NAc. Differenceaya daga cikin bambance bambancen jima'i shine karuwar magana ta DAT mRNA a cikin mace ta VTA bayan HFD. Wannan bambanci a cikin bayanin martaba, hade tare da raguwa iri ɗaya a cikin bayanin martaba na TH a cikin maza da mata, zai ba da shawarar bambance-bambance masu mahimmanci a cikin ƙwayar ƙwaƙwalwar dopamine a cikin NAc, duka a ƙarshen bayyanar HFD da kuma bayan lokacin murmurewa. Babban godiya ga mahimmancin aikin waɗannan bambance-bambancen shine muhimmin abin da aka sa a gaba na bincike na gaba.

Bugu da ƙari, yayin da COMT da TH ke raguwa a cikin VTA na maza, waɗannan raguwa sun ci gaba a cikin mata bayan 4-mako kashe HFD. Har yanzu dai ba a tantance ko ire-iren wadannan bambance-bambancen za su juya baya tare da cin dogon lokaci ba, amma, yana goyan bayan matsayin cewa mata sun kasance a hankali, a hankali kadan su murmure, idan suka murmure kwata-kwata. Bugu da ari, canje-canjen magana da dan adam na D1R da D2R a NAc da PFC sun banbanta sosai tsakanin maza da mata. A cikin maza, an sami raguwa gaba ɗaya cikin maganganun ɗimbin yawa a cikin yankuna biyu waɗanda ke daɗaɗɗe bayan cire abinci. A cikin mata, D1R da D2R sun ragu a cikin NAc sannan a dawo dasu, amma babu wani sakamako na HFD akan masu karban dopamine a cikin PFC. A cikin karatun na yanzu, an yanka dabbobi mata ba tare da yin lissafin matakan estrus ba. Duk da yake wasu daga cikin abubuwan lura da aka sani sun bambanta a duk faɗin yanayin estrus, dabbobin mata a cikin wannan binciken ba su nuna bambancin haɓakawa a ƙarshen ƙarshen ba, musamman idan aka kwatanta da tasirin cin abincin.

Don ƙara wa binciken bayyanar kwayoyin halitta, an auna dopamine a cikin manyan yankunan VTA, wato PFC da NAc. Matakan dopamine sun fi nuna canje-canje iri ɗaya da aka gani a cikin TH mRNA a cikin VTA. A cikin NAc na maza da mata, matakan DA sun ragu a martanin abincin HFD; martanin da ya warke a cikin maza, amma ba mata ba. A cikin PFC, matakan dopamine suma sun ragu ta hanyar HFD, duk da haka, babu murmurewa daga abinci a cikin PFC. Bugu da ƙari, mata suna da ƙananan matakan dopamine a cikin prefrontal cortex fiye da maza. Bambance-bambancen jinsi a cikin bayyanar DAT da aiki sananne ne a cikin wallafe-wallafe, tare da mata suna nuna ƙaruwar bayyanar DAT ( ) da aiki ( ), kuma waɗannan bambance-bambancen na iya ba da gudummawa ga matakan asali daban-daban na dopamine tsakanin maza da mata. Binciken rabon DOPAC:DA kuma yana da bayanai. Ƙara wannan rabo na iya nuna martanin diyya wanda raguwar DA ke haifarwa. Muhimmancin aiki na dogon lokaci na waɗannan canje-canje a cikin metabolism na dopamine za a haskaka ta hanyar auna canje-canje a cikin sakin dopamine ta amfani da in vivo microdialysis.

Bugu da ƙari, waɗannan bayanan sun gano tsarin methylation na DNA mai ƙarfi a cikin mai haɓaka kwayar halittar DAT, musamman a cikin maza. Kwanan nan, mun nuna cewa ana iya sarrafa bayyanar DAT ta hanyar methylation na DNA daban-daban don mayar da martani ga HFD ( ), kuma cewa ƙaruwar methylation na mai haɓaka DAT yana da alaƙa da raguwar bayyanar kwayar halitta. A nan mun gano ƙarfin wannan martanin, yayin da ƙaruwar methylation na DNA (da raguwar bayyanar mRNA) da aka gani a cikin maza ke juyawa bayan cire HFD. Tsarin kwayoyin halittar Epigenetic, misali ta hanyar canje-canje a cikin methylation na DNA, yana gabatar da hanyar da kwayoyin halitta za su iya daidaitawa cikin sauƙi ga ƙalubalen muhalli. Ana iya kiyaye alamun Epigenetic a tsawon rayuwa ( ), kuma a cikin ƙwayoyin halittar da aka haɓaka da ƙwayoyin halittar tayi, an lura da alamu masu canzawa da masu dorewa na bambancin methylation na DNA dangane da canjin yanayin muhalli ( ). Waɗannan bayanan sune farkon waɗanda suka nuna a cikin rayuwa wani tsarin methylation mai ƙarfi wanda ke canzawa tare da kasancewar ko rashin ƙalubalen muhalli. Abin lura ne cewa ba a lura da wannan tsarin a cikin mata ba. Duk da cewa martanin farko ga HFD ya kasance kamar yadda aka annabta (raguwar methylation na DNA yana haifar da ƙaruwar bayyanar kwayoyin halitta), wannan tsarin ba a kiyaye shi ba a duk tsawon lokacin murmurewa. Wannan yana nuna cewa methylation na DNA da bayyanar kwayoyin halitta na iya zama ba a haɗa su ba a cikin makonni huɗu na HFD ko kuma yana iya nuna cewa ana sarrafa DAT mRNA ta wasu hanyoyi a cikin mata.

A cikin maza, fifiko na maye gurbinsa, magana da ke da alaƙa ta hanyar DA a cikin VTA, da kuma dopamine a cikin NAc suna bin tsari mai daidaituwa, na kumburi a cikin martani ga ƙarancin HFD wanda ke murmurewa bayan cire abincin. Abin sha'awa, yayin da martani ga halaye yake kama da mace, duka tsarin tsarin magana da matakan NAc dopamine suna nuna rashin warkewa yayin cire HFD. Halin da ke da alaƙa da sakamako yana da tasiri a fili ta ƙarin tsarin neurotransmitter kamar opioids, kuma watakila a cikin mace, amsawar halayen don sucrose yana da alaƙa da canje-canje a cikin opioids. Gabaɗaya, bayanan da ke yanzu suna ba da shawarar cewa bambance-bambancen jima'i a cikin duka farkon farkon amsawar HFD, kazalika don dawo da bayan cire HFD, dangane da batun magana game da ɗimbin kwayar dopamine yana wakiltar muhimmiyar jagora don binciken da aka gabatar nan gaba game da yadda ake amfani da ƙwayar cuta ta yau da kullun. HFD yana tasiri akan tsarin sakamako na kwakwalwa. Mafi mahimmanci, waɗannan bayanan suna gano mahimmancin ƙwayar cuta a cikin amsawar dopaminergic ga HFD, suna ba da shawara cewa yayin da mummunan tasirin amfani da ƙwayar HFD na kullum da / ko kiba yana da mahimmanci, yuwuwar murmurewa ya kasance.

Abinda aka riga sani game da wannan batun

  • Bayanin Dopamine mai karɓa da aiki yana raguwa a cikin masu fama da kiba
  • Bayyanar yau da kullun ga mai kitse mai yawa yana haifar da canje-canje a cikin kwayoyin halittar dopamine da halayyar sakamako
  • Dopamine neurotransmission an canza shi a cikin ƙoshin ƙwayoyin cuta masu kiba.

Abinda wannan rubutun yake karawa ga batun

  • Bayyanar da bambance-bambance na jima'i a cikin martanin CNS ga abincin mai mai yawa.
  • Kimantawa da filastik na canje-canje na dopaminergic kan cirewar abincin mai mai mai yawa.
  • Bayyanar daskararren kwayar halitta na DNA yana canzawa a cikin martani ga abincin mai mai yawa

Karin kayan

Acknowledgments

An tallafawa wannan aikin ta hanyar tallafin mai zuwa: MH087978 (TMR), MH86599 (IL), da T32 GM008076 (JLC).

Bayanan kalmomi

 

Rikice-rikice Bayanin Sha'awa

Marubutan ba su da rikice-rikice don bayyanawa.

 

References

1. Swinburn B, Sacks G, Ravussin E. energyara yawan samar da abinci mai ƙarfi ya wadatar don bayyana bala'in cutar ƙwayar cuta ta Amurka. Am J Clin Nutr. 2009; 90: 1453 – 1456. [PubMed]
2. Fibiger HC, Phillips AG. Mesocorticolimbic dopamine tsarin da lada. Ann NY Acad Sci. 1988; 537: 206 – 215. [PubMed]
3. Hernandez Luis, Hoebel Bartley G. Sakamakon Abinci da Cocaine suna Kara Dopamine na Jinkiri a cikin Abubuwan Nucleus kamar yadda aka auna ta Microdialysis. Kimiyyar Rayuwa. 1988; 42 (18): 1705 – 1712. [PubMed]
4. Sahr Allison E, Sindelar Dana K, Alexander-Chacko Jesline T, Eastwood Brian J, Mitch Charles H, Statnick Michael A. Kunna Mesolimbic Dopamine Neurons Yayin Novel da Daily Limited Access to Palatable Abinci An toshe ta Opioid Antagonist LY255582. American Journal of Physiology - Tsarin Mulki, Haɗaka da Kwatancen Jiki. 2008 Aug 1; 295 (2): R463-R471. [PubMed]
5. Stice E, Spoor S, Bohon C, Daramar DM. Lationarfafawa tsakanin kiba da ƙarancin amsawa game da abinci ana daidaita shi ta TaqIA A1 allele. Kimiyya. 2008; 322: 449 – 452. [PMC free article] [PubMed]
6. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Haɗin kai na D2 nau'in mai karɓa na dopamine tare da halayen mai riƙewa-da ke cikin maye. Arch Gen Psychiatr. 1991; 48: 648 – 654. [PubMed]
7. Chen PS, Yang YK, Yeh TL, Lee IH, Yao WJ, Chiu NT, et al. Amincewa tsakanin jigon jiki da kuma jigilar jigilar dopamine a cikin masu bayar da agaji na lafiya - Nazarin SPVE. Neuroimage. 2008; 40 (1): 275 – 279. [PubMed]
8. Bukatar AC, Ahmadi KR, Spector TD, Goldstein DB. Kiba mai Girma An Haɗu da Batutuwa Masu Halittu waɗanda ke Samun Samun Dopamine. Labarun Tarihin Humanan Adam. 2006 May; 70 (Pt 3): 293 – 303. [PubMed]
9. Geiger BM, Frank LE, Caldera-siu AD, Stiles L, Pothos EN. Rashin ƙwayoyin dopamine na tsakiya a cikin samfuran kiba masu yawa. Ci. 2007; 49 (1): 293.
10. Geiger BM, Haburcak M, Avena NM, Moyer MC, Hoebel BG, Pothos EN. Kasawar mesolimbic dopamine neurotransmission a cikin kiba mai kiba. Neuroscience. 2009 Apr 10; 159 (4): 1193 – 119. [PMC free article] [PubMed]
11. Cone JJ, Robbins HA, Roitman JD, Roitman MF. Amfani da abinci mai mai mai yawa yana shafar fasalin dopamine da sake farfadowa cikin tarin ƙwayoyin cuta. Ci. 2010 Jun; 54 (3): 640.
12. Vucetic Zivjena, Carlin Jesselea, Totoki Kathy, Reyes Teresa M. Epigenetic Dysregulation na Tsarin Dopamine a cikin Cutar Abinci. Jaridar Neurochemistry. 2012 Jan 5; [PMC free article] [PubMed]
13. Alsiö J, Olszewski PK, Norbäck AH, Gunnarsson ZEA, Levine AS, Pickering C, Schiöth HB. Dopamine D1 Receptor Gene Fadakarwa Ragewa a cikin Nucleus Asarar Bayan bayyanar Dogon Abinci ga Abincin Palatable da Bambanci Ya danganta da Yawan Abincin da ke haifar da Phenotype na Rats. Neuroscience. 2010 Dec 15; 171 (3): 779 – 787. [PubMed]
14. Johnson Paul M, Kenny Paul J. Dopamine masu karɓa na D2 a cikin jaraba-kamar Rashin wardari da Comparfin Abinci a cikin Rashin Obese. Yanayin Neuroscience. 2010 May; 13 (5): 635 – 641. [PMC free article] [PubMed]
15. Huang Xu-Feng, Yu Yinghua, Zavitsanou Katerina, Han Mei, Storlien Len. Bambancin magana da dopamine D2 da D4 mai karɓa da tyrosine hydroxylase mRNA a cikin mice prone, ko juriya, ga mai kiba mai-yawan abincin da ke haifar da kiba. Binciken Kwakwalwar kwakwalwa. 2005 Apr 27; 135 (1 – 2): 150 – 161. [PubMed]
16. Teegarden SL, Scott AN, Bale TL. Bayyanar rayuwar farko zuwa ga mai kitse yana haɓaka canje-canje na dogon lokaci a abubuwan da ake buƙata na abinci da kuma alamar lada ta tsakiya. Neuroscience. 2009 Sep 15; 162 (4): 924 – 932. [PMC free article] [PubMed]
17. Bouret SG. Rawar Hwararrun Ma'aunin Jiki da Lafiyar Jiki a Tsarin Ciyar da Ciyar da Ciyar da Jiki. Jaridar Abinci. 2010 Jan 1; [PubMed]
18. Vucetic Z, Kimmel J, Totoki K, Hollenbeck E, Reyes TM. Abincin Fat mai Abinci ya Shafi Methylation da Bayyanar Kwayar cutar Dopamine da Kwayoyi masu alaƙa da Opioid. Endocrinology. 2010 Oct; 151 (10): 0000 – 0000. [PMC free article] [PubMed]
19. Reyes Teresa M, Walker John R, DeCino Casey, Hogenesch John B, Sawchenko Paul E. Masu rarrabuwar reswararrun Maƙasudan Jigilar Bayyana Bayanan Halittar Bayanan Halittu a cikin Tsarin Tsarin Hypothalamus. Jaridar Neuroscience: The Official Journal of the Society for Neuroscience. 2003 Jul 2; 23 (13): 5607 – 5616. [PubMed]
20. Cleck Jessica N, Ecke Laurel E, Blendy Julie A. Endocrine da Maganar Fadakarwa Yan Sanda Bayan Canjin Fuskantar Tsintsiya Masu Tsinkaye A Lokacin Zubewar Cocaine a Mice. Psychopharmacology. 2008 Nov; 201 (1): 15 – 28. [PMC free article] [PubMed]
21. Ffaffl MW. Wani sabon salo na lissafi don rarrabuwa cikin ainihin rt-pcr. Residik Acids Res. 2001; 20: e45. [PMC free article] [PubMed]
22. Mayorga AJ, Dalvi A, Shafin ME, Zimov-Levinson S, Hen R, Lucki I. Antidepressant-kamar tasirin halayen 5-hydroxytryptamine (1A) da 5-hydroxytryptamine (1B) mice masu amfani da jijiyoyi. J Pharmacol Exp Ther. 2001; 298: 1101 – 110. [PubMed]
23. Vucetic Z, Kimmel J, Reyes TM. Abincin mai mai na yau da kullun ya kori direbobi na nat-Opioid Receptor a cikin Brain. Neuropsychopharmacology. 2011 doi: 10.1038 / npp.2011.4. gabatarwa kan layi akan layi 16 Fabrairu 2011. [PMC free article] [PubMed] [Cross Ref]
24. Davis JF, Tracy AL, Schurdak JD, Tschöp MH, Lipton JW, Clegg DJ, et al. Bayyanar zuwa matakan da aka samu na kitse mai narkewa yana haifar da sakamako na psychostimulant da kuma juyawar mesolimbic dopamine a cikin bera. Behav Neurosci. 2008; 122 (6) [PMC free article] [PubMed]
25. de Araujo Ivan E, Oliveira-Maia Albino J, Sotnikova Tatyana D, Gainetdinov Raul R, Caron Marc G, Nicolelis Miguel AL, Simon Sidney A. Sakamakon Abinci a cikin Rashin Tasirin Abin karɓa na Tasteor. Neuron. 2008 Mar 27; 57 (6): 930 – 941. [PubMed]
26. Beeler Jeff A, McCutcheon James E, Cao Zhen FH, Murakami Mari, Alexander Erin, Roitman Mitchell F, Zhuang Xiaoxi. Ku ɗanɗani Abincin da ya samo asali daga Abincin Abinci ya kasa Cike kayan abinci. Jaridar Turai ta Nazarin ilimin halittar kwakwalwa. 2012 Aug; 36 (4): 2533 – 2546. [PMC free article] [PubMed]
27. Dus Monica, Min SooHong, Keene Alex C, Lee Ga Sun, Suh Greg SB. Gano independentanƙarar Abun Kalam na sukari a cikin Drosophila. Yanke Karatun Kwalejin Kimiyya ta Kasa ta Amurka. 2011 Jul 12; 108: 11644 – 11649. [PMC free article] [PubMed]
28. Wang Gene-Jack, Volkow Nora D, Logan Jean, Pappas Naoml R, Wong Christopher T, Zhu Wel, Netusll Noelwah, Fowler Joanna S. Brain dopamine da kiba. A Lancet. 2001; 357 (9253): 354 – 357. [PubMed]
29. Huang XF, Zavitsanou K, Huang X, Yu Y, Wang H, Chen F, et al. Mai jigilar Dopamine da mai karɓa mai karɓar D2 mai ɗaukar ƙima a cikin mice yana da haɗari ko tsayayya da ƙarancin kiba mai yawa wanda ke haifar da kiba. Behav Brain Res. 2006; 175 (2): 415 – 419. [PubMed]
30. Fortuna Jeffrey L. Bala'in Maganin Kiba da ictionarfafa Abinci: Similarabi'a na asibiti don Dogaro da Magunguna. Jaridar Magungunan Magunguna. 2012 Mar; 44 (1): 56 – 63. [PubMed]
31. Koob George F, Moal Michel Le. Addiction da Brain Antireward System. Nazarin Nazari na shekara-shekara na Ilimin halin .an Adam. 2008; 59: 29 – 53. [PubMed]
32. Speed ​​Nicole, Saunders Christine, Davis Adeola R, Anthony Owens W, Matthies Heinrich JG, Saadat Sanaz, Kennedy Jack P, et al. Paarfafa Akt Alamar ƙwayar Akt ta rikicewar cututtukan ƙwayar cuta na Dopamine kuma yana ƙaruwa da Ciyar. PLOS DAYA. 2011 Sep 28; 6 (9) doi: 10.1371 / journal.pone.0025169. [PMC free article] [PubMed] [Cross Ref]
33. Sharma S, Fulton S. Abubuwan da ke haifar da Kiba mai Promari yana Haɓaka Deparfin Rashin tausayi-kamar Halayyar Thatwaƙwalwa da Haɗaɗɗun Daidaita Tsarin Mulkin Cikin Braaƙwalwar inarfin Brain. Labaran Duniya na Kiba 2005. 2012 Apr 17; [PubMed]
34. Steele Kimberley E, Prokopowicz Gregory P, Schweitzer Michael A, Magunsuon Thomas H, Lidor Anne O, Kuwabawa Hiroto, Kumar Anil, Brasic James, Wong Dean F. Canjin Magungunan Dopamine na Tsakanin Kafin da Bayan Gyaran Gyaran Jiki. Kiba mai Wuya. 2009 Oct 29; 20 (3): 369 – 374. [PubMed]
35. Phelan Suzanne, Wing Rena R, Loria Catherine M, Kim Yongin, Lewis Cora E. Rikice-rikice da Masu Hasashen Harkokin Rage nauyi da aabi'a a cikin Biracial: Sakamako daga Harkokin Halittar Halittar Rana a Matasa Matasa. American Journal of rigakafin Magunguna. 2010 Dec; 39 (6): 546 – 554. [PMC free article] [PubMed]
36. Field AE, Wing RR, Manson JE, Spiegelman DL, Willett WC. Dangantaka da Babban Rasa Tsinkaye zuwa Canjin Tsinkaye Na Tsayi Tsakanin Womenan Matasa da Middlean Tsakanin Amurka. Jaridar kasa da kasa ta Maganin Kiba da Rashin Tsarin Kiba: Journal of the International Association for Nazarin Kiba. 2001 Aug; 25 (8): 1113 – 1121. [PubMed]
37. Morissette M, Di Paolo T. Jima'i da Estrous Tsarancin Safiya na Rat Striatal Dopamine Uptake Sites. Neuroendocrinology. 1993 Jul; 58 (1): 16 – 22. [PubMed]
38. Bhatt Sandeep D, Dluzen Dean E. Dopamine Aikin Aiwatar da Jirgin Ruwa Tsakanin Mace da Mace CD-1. Binciken Kwakwalwa. 2005 Feb 28; 1035 (2): 188 – 195. doi: 10.1016 / j.brainres.2004.12.013. [PubMed] [Cross Ref]
39. Ollikainen Miina, Smith Katherine R, Joo Eric Ji-Hoon, Hong Kiat Ng, Andronikos Roberta, Novakovic Boris, et al. Nazarin DNA na Methylation na Tissues da yawa daga Newan Jariri Ya Bayyana Dukkan Kwayoyin Halittu da Jikin Injiuterine zuwa Canji a cikin Epigenome na onan Adam. Halittar kwayoyin halittar mutum. 2010 Nov 1; 19 (21): 4176 – 4188. [PubMed]
40. Tompkins Joshua D, Hall Christine, Chen Vincent Chang-yi, Li Arthur Xuejun, Wu Xiwei, Hsu David, et al. Cigaban Epigenetic, Adaidaitawa, da kuma Canzawa cikin Suwayen Halittar Dan Adam. Yanke Karatun Kwalejin Kimiyya ta Kasa ta Amurka. 2012 Jul 31; 109 (31): 12544 – 12549. [PMC free article] [PubMed]